Trial Details

COMPLETED
Basic Information
Clinical ID c3625
Identifier NCT01769755
Trial Title A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohns Disease
Interventions BIOLOGICAL: PDA001|DRUG: Vehicle Controlled Placebo
Participant Information
Sponsor Celularity Incorporated
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2013-03
Primary Completion Date 2014-11
Completion Date 2014-11